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Abstract:	
Introduction:	The	impact	of	sleep	on	quality	of	life	(QoL)	has	been	well	documented;	however,	there	is	a	
great	need	for	reliable	QoL	measures	for	persons	with	obstructive	sleep	apnea	(OSA).	We	compared	the	
QoL	scores	between	the	36-Item	Short	Form	of	the	Medical	Outcomes	Survey	(SF-36),	Calgary	Sleep	
Apnea	Quality	of	Life	Index	(SAQLI),	and	Functional	Outcomes	Sleep	Questionnaire	(FOSQ)	in	persons	
with	OSA.	
Methods:	A	total	of	884	participants	from	the	Sleep	Heart	Health	Study	second	examination,	who	
completed	the	SF-36,	FOSQ,	and	SAQLI,	and	in-home	polysomnograms,	were	included.	The	apnea	
hypopnea	index	(AHI)	at	4%	desaturation	was	categorized	as	no	OSA	(<5	/hour),	mild	to	moderate	OSA	
(5-30	/hour)	and	severe	OSA	(>30	/hour).	QoL	scores	for	each	questionnaire	were	determined	and	
compared	by	OSA	severity	category	and	by	gender.	
Results:	Participants	were	47.6%	male,	49.2%	(n=435)	had	no	OSA,	43.2%	(n=382)	had	mild	to	moderate	
OSA,	and	7.6%	(n=67)	had	severe	OSA.	Participants	with	severe	OSA	were	significantly	older	(mean	age	=	
63.7	years,	p	<.0001),	had	higher	BMI	(mean	=	34.3	kg/m2,	p	<.0001)	and	had	lower	SF-36	Physical	
Component	scores	(PCS)	(45.1)	than	participants	with	no	OSA	(48.5)	or	those	with	mild	to	moderate	OSA	
(46.5,	p=	.006).	When	analyzed	according	to	gender,	no	significant	differences	were	found	in	males	for	
QoL	by	OSA	severity	categories.	However,	females	with	severe	OSA	had	significantly	lower	mean	scores	
for	the	SAQLI	(5.4,	p=	.006),	FOSQ	(10.9,	p=	.02),	and	SF-36	PCS	(37.7,	p<.0001)	compared	to	females	
with	no	OSA	(6.0,	11.5,	44.6)	and	those	with	mild	to	moderate	OSA	(5.9,	11.4,	48,	respectively).	Females	
with	severe	OSA	also	had	significantly	higher	mean	BMI	(41.8	kg/m2,)	than	females	with	no	OSA	(26.5	
kg/m2)	or	females	with	mild	to	moderate	OSA	(30.6	kg/m2,	p<.0001).	The	SF-36	PCS	and	Mental	
Component	Scores	(MCS)	were	correlated	with	the	FOSQ	and	SAQLI	(r=.37	PCS	vs	FOSQ;	r=.31	MCS	vs	
FOSQ;	r=.42	PCS	vs	SAQLI;	r=.52	MCS	vs	SAQLI;	and	r=.66	FOSQ	vs	SAQLI,	p<.001	for	all	correlations).	
Linear	regression	analyses,	adjusting	for	potential	confounders,	indicated	that	the	impact	of	OSA	
severity	on	QoL	is	largely	explained	by	the	presence	of	daytime	sleepiness.	
Conclusion:	The	impact	of	OSA	on	QoL	differs	between	genders	with	a	larger	effect	on	females	and	is	
largely	explained	by	the	presence	of	daytime	sleepiness.	Correlations	among	QoL	instruments	are	not	
high	and	various	instruments	may	assess	different	aspects	of	QoL.	
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Introduction:	
Obstructive	sleep	apnea	(OSA)	is	a	highly	prevalent	condition	occurring	in	as	many	as	17%	and	
9%	of	middle	aged	males	and	females,	respectively.(1)	OSA	is	now	recognized	as	an	important	risk	factor	
for	the	development	of	hypertension	and	coronary	heart	disease	as	well	as	premature	death.(2)	
However,	patients	frequently	present	to	health	care	providers	with	symptoms	that	are	indicative	of	
impairment	in	their	quality	of	life	(QoL).	Improvement	in	QoL	is	an	important	determinant	of	whether	
patients	adhere	to	continuous	positive	airway	pressure	(CPAP),	the	most	commonly	prescribed	
treatment	for	OSA.	Additionally,	measurement	of	QoL	is	one	of	the	quality	metrics	recently	developed	
for	use	in	clinical	practice,(3)	thus	increasing	the	importance	of	evaluating	tools	used	to	assess	QoL	in	
OSA.	
A	variety	of	tools	to	measure	QoL	have	been	utilized	in	epidemiologic	studies	and	clinical	trials	
of	OSA.	The	most	common	general	QoL	instrument	used	has	been	the	Medical	Outcomes	Study	Short-
Form	Health	Survey	SF-36.(4)	More	recently,	two	sleep	specific	QoL	questionnaires	have	been	
developed,	the	Functional	Outcomes	of	Sleep	Questionnaire	(FOSQ)(5)	and	the	Sleep	Apnea	Quality	of	
Life	Inventory	(SAQLI).(6)	Whether	these	sleep	specific	QoL	instruments	are	more	sensitive	in	those	with	
OSA	than	general	QoL	questionnaires	is	not	clear.	Furthermore,	there	have	been	few	comparisons	of	the	
FOSQ	to	the	SAQLI	with	respect	to	their	sensitivity	in	those	with	OSA	and	whether	QoL	differs	between	
males	and	females.	Using	data	from	a	large	cohort	study,	the	purposes	of	these	analyses	were	to	
compare	these	instruments	to	each	other,	to	assess	whether	they	were	able	to	detect	differences	in	QoL	
among	groups	with	different	severities	of	OSA	and	to	determine	whether	there	were	differences	
between	genders.	
Methods:	
The	Sleep	Heart	Health	Study	(SHHS)	is	a	prospective	multicenter	cohort	study	designed	to	
investigate	the	relationship	between	OSA	and	cardiovascular	diseases	in	the	United	States.	Details	of	the	
study	design	have	been	published	elsewhere.(7)	Briefly,	initial	baseline	recruitment	began	in	1995,	
enrolling	6,441	subjects,	40	years	of	age	and	older,	from	several	ongoing	geographically	distinct	
cardiovascular	and	respiratory	disease	cohorts	who	were	initially	assembled	between	1976	and	1995.(8)	
These	cohorts	included	the	Offspring	Cohort	and	the	Omni	Cohort	of	the	Framingham	Heart	Study	in	
Massachusetts;	the	Hagerstown,	MD,	and	Minneapolis,	MN,	sites	of	the	Atherosclerosis	Risk	in	
Communities	Study;	the	Hagerstown,	MD,	Pittsburgh,	PA,	and	Sacramento,	CA,	sites	of	the	
Cardiovascular	Health	Study;	3	hypertension	cohorts	(Clinic,	Worksite,	and	Menopause)	in	New	York	
City;	the	Tucson	Epidemiologic	Study	of	Airways	Obstructive	Diseases	and	the	Health	and	Environment	
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Study;	and	the	Strong	Heart	Study	of	American	Indians	in	Oklahoma,	Arizona,	North	Dakota,	and	South	
Dakota.	A	SHHS	follow-up	examination	took	place	between	February	2000	and	May	2003,	enrolling	
4,586	of	the	original	participants	who	had	a	repeat	polysomnogram	in	addition	to	completing	
questionnaires	and	undergoing	other	measurements.	The	present	study	focused	on	884	participants	
from	the	Tucson	and	Framingham	sites	of	the	Sleep	Heart	Health	Study	second	examination	in	whom	
data	were	available	from	the	sleep	habits	questionnaire,	all	quality	of	life	questionnaires,	and	in-home	
polysomnograms.	Data	was	limited	to	these	sites	because	administration	of	the	FOSQ	was	not	done	at	
the	other	field	centers.			
The	SHHS	was	approved	by	the	respective	institutional	review	boards	for	human	subjects	
research,	and	informed	written	consent	was	obtained	from	all	subjects	at	the	time	of	their	enrollment	
into	each	stage	of	the	study.	
Polysomnography	
Participants	underwent	overnight	in-home	polysomnograms	using	the	Compumedics	Portable	
PS-2	System	(Abbottsville,	Victoria,	Australia)	administered	by	trained	technicians.(9)			Briefly,	after	a	
home	visit	was	scheduled,	the	Sleep	Health	Questionnaire,	SF-36,	SAQLI,	and	FOSQ	questionnaires	
generally	were	mailed	1	to	2	weeks	prior	to	the	in-home	polysomnography	appointment.	Each	
participant	was	asked	to	complete	the	questionnaire	before	the	home	visit,	at	which	time	the	
questionnaires	were	collected	and	verified	for	completeness.	The	home	visits	were	performed	by	two-
person,	mixed-sex	teams	in	visits	that	lasted	1.5	to	2	hours.	There	was	emphasis	on	making	the	night	of	
the	polysomnographic	assessment	as	representative	as	possible	of	a	usual	night	of	sleep.	Participants	
were	asked	to	schedule	the	visit	so	that	it	would	occur	approximately	two	hours	prior	to	their	usual	
bedtime.	Participants’	weekday	or	weekend	bedtime	routines	were	encouraged	to	be	consistent	with	
the	day	of	the	week	that	the	visits	were	made.		
The	SHHS	recording	montage	consisted	of	electroencephalogram	(C4/A1	and	C3/A2),	right	and	left	
electrooculogram,	a	bipolar	submental	electromyogram,	thoracic	and	abdominal	excursions	(inductive	
plethysmography	bands),	airflow	(detected	by	a	nasal-oral	thermocouple	[Protec,	Woodinville,	WA]),	
oximetry	(finger	pulse	oximetry	[Nonin,	Minneapolis,	MN]),	electrocardiogram	and	heart	rate	(using	a	
bipolar	electrocardiogram	lead),	body	position	(using	a	mercury	gauge	sensor),	and	ambient	light	
(on/off,	by	a	light	sensor	secured	to	the	recording	garment).	Sensors	were	placed,	and	equipment	was	
calibrated	during	an	evening	home	visit	by	a	certified	technician.	After	technicians	retrieved	the	
equipment,	the	data,	stored	in	real	time	on	PCMCIA	cards,	were	downloaded	to	the	computers	of	each	
respective	clinical	site,	locally	reviewed,	and	forwarded	to	a	central	reading	center	(Case	Western	
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Reserve	University,	Cleveland,	OH).	Comprehensive	descriptions	of	polysomnography	scoring	and	
quality-assurance	procedures	have	been	previously	published.(9,	10)	In	brief,	sleep	was	scored	
according	to	guidelines	developed	by	Rechtschaffen	and	Kales.(11,	12)	Strict	protocols	were	maintained	
to	ensure	comparability	among	centers	and	technicians.	Intra-scorer	and	inter-scorer	reliabilities	were	
high.(10)	As	in	previous	analyses	of	SHHS	data,	an	apnea	was	defined	as	a	complete	or	almost	complete	
cessation	of	airflow,	as	measured	by	the	amplitude	of	the	thermocouple	signal,	lasting	at	least	10	
seconds.	Hypopneas	were	identified	if	the	amplitude	of	a	measure	of	flow	or	volume	(detected	by	the	
thermocouple	or	thorax	or	abdominal	inductance	band	signals)	was	reduced	discernibly	(at	least	25%	
lower	than	baseline	breathing)	for	at	least	10	seconds	and	did	not	meet	the	criteria	for	apnea.	For	this	
study,	only	apneas	or	hypopneas	associated	with	a	4%	or	greater	oxyhemoglobin	desaturation	were	
considered	in	the	calculation	of	the	apnea	hypopnea	index	(AHI,	apneas	plus	hypopneas	per	hour	of	
total	sleep	time).		
Sleep	Habits	Questionnaire	and	Covariates	
Participants	completed	the	SHHS	Sleep	Habits	Questionnaire.(13)	The	Sleep	Habits	
Questionnaire	contained	questions	regarding	sleep	habits.	Height	and	weight	were	measured	directly	to	
determine	body	mass	index	(BMI,	kg/m2).	Sex	and	ethnicity	were	derived	from	data	obtained	from	the	
SHHS	parent	cohorts.	Participants	answered	yes	or	no	to	having	a	healthcare	provider	diagnosing	them	
as	having	chronic	obstructive	pulmonary	disease	(COPD),	chronic	bronchitis,	or	asthma.	
Sleepiness		
The	level	of	daytime	sleepiness	was	determined	using	the	Epworth	Sleepiness	Scale	(ESS),	a	
validated	8-item	questionnaire	that	measures	subjective	sleepiness.(14)	Subjects	were	asked	to	rate	
how	likely	they	are	to	fall	asleep	in	different	situations.	Each	question	was	answered	on	a	scale	of	0	to	3.	
ESS	values	ranged	from	0	(unlikely	to	fall	asleep	in	any	situation)	to	24	(high	chance	of	falling	asleep	in	all	
8	situations).	Mean	ESS	scores	between	14	and	16	have	been	reported	for	patients	with	OSA.(14,	15)	
Scores	of	11	or	greater	are	considered	to	represent	an	abnormal	degree	of	daytime	sleepiness.(16)	
Sleepiness	was	defined	as	an	ESS	of	at	least	10.		
Quality	of	Life	Measures	
Medical	Outcomes	Study	Short-Form	Health	Survey	(SF-36)		
Quality	of	life	was	evaluated	using	the	Medical	Outcomes	Study	Short-Form	Health	survey	(SF-
36).(4)	The	SF-36	is	a	multipurpose	self-administered	health	survey	consisting	of	36	questions	divided	
into	8	individual	domains:	(1)	physical	functioning	(limitations	in	physical	activity	because	of	health	
problems),	(2)	role	physical	(limitations	in	usual	role	activities	because	of	physical	health	problems),	(3)	
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bodily	pain,	(4)	general	health	perceptions;	(5)	vitality	(energy	and	fatigue),	(6)	social	functioning	
(limitation	in	social	activities	because	of	physical	or	emotional	problems),	(7)	role	emotional	(limitation	
in	usual	role	activities	because	of	emotional	problems),	and	(8)	general	mental	health.	In	addition,	the	8	
scales	are	used	to	form	2	distinct	high-order	summary	scales:	the	physical	component	summary	(PCS)	
and	the	mental	component	summary	(MCS).(17)	The	PCS	includes	the	physical	functioning,	role	physical,	
bodily	pain,	and	general	health	scales,	and	the	MCS	includes	the	vitality,	social	functioning,	role	
emotional,	and	general	mental	health	scales.	The	raw	scores	for	each	subscale	and	the	2	summary	
measures	are	standardized,	weighted,	and	scored	according	to	specific	algorithms.	The	scores	for	the	
multifunction	item	scales	and	the	summary	measures	range	from	0	to	100,	with	higher	scores	indicating	
better	quality	of	life.	For	the	present	study,	we	use	only	the	PCS	and	MCS	scales.	
Functional	Outcomes	Sleep	Questionnaire	(FOSQ)		
	 The	FOSQ	was	developed	as	a	self-report	instrument	to	assess	the	disorders	of	sleepiness	on	
quality	of	life.	It	consists	of	30	items	with	5	factor-based	subscales:	activity	level,	vigilance,	intimacy	and	
sexual	relationships,	general	productivity	and	social	outcome.	A	mean	weighted	item	score	is	obtained	
for	each	subscale.	The	subscales	are	summed	to	produce	a	global	score.(5)	In	SHHS,	questions	related	to	
sexual	intimacy	were	omitted	because	there	were	concerns	that	some	participants	would	find	these	
embarrassing	or	offensive.		
		 Sleep	Apnea	Quality	of	Life	Index	(SAQLI)	
The	SAQLI	was	developed	as	a	sleep	apnea	specific	quality	of	life	instrument.(6)	It	is	a	35	item	
instrument	that	captures	the	adverse	impact	of	sleep	apnea	on	4	domains:	daily	functioning,	social	
interactions,	emotional	functioning,	and	symptoms.	Items	are	scored	on	a	7-point	scale	with	“all	of	the	
time”	and	“not	at	all”	being	the	most	extreme	responses.	Item	and	domain	scores	are	averaged	to	yield	
a	composite	total	score	between	1	and	7.	Higher	scores	represent	better	quality	of	life.	In	SHHS,	the	
short	form	of	the	SAQLI	was	administered,	because	it	allowed	for	self-completion	by	the	
participants.(18)	
Statistical	Analysis	
	 Differences	in	proportions	for	descriptive	characteristics	between	OSA	severity	categories,	and	
categorical	variables	were	analyzed	using	Chi-square	tests	with	2	degrees	of	freedom.	Fisher’s	exact	test	
was	used	when	the	expected	frequency	was	less	than	5	in	any	cell.	One-way	analyses	of	variance	
(ANOVA)	were	used	to	compare	differences	in	mean	values	for	continuous	variables	(BMI,	total	sleep	
time,	SAQLI,	FOSQ,	SF-36	MCS,	and	SF-36	PCS)	by	OSA	severity	categories	and	by	these	categories	
separately	for	males	and	females.	Pearson’s	correlations	were	used	to	test	for	correlation	coefficients	
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between	the	four	quality	of	life	scales,	SAQLI,	FOSQ,	SF-36	MCS,	and	SF-36	PCS.	
Separate	multivariate	linear	regression	models	were	fitted	to	evaluate	scores	from	each	of	the	
four	QoL	scales	by	OSA	categories	for	males	and	females.	Potential	confounders	(age,	race,	COPD,	
chronic	bronchitis,	ESS	and	asthma)	were	evaluated	and	adjusted	for	in	the	models;	only	those	variables	
with	significant	coefficients	were	kept	in	the	models.	Thus,	OSA	severity,	ESS,	and	asthma	were	the	only	
variables	retained	in	the	final	models.	All	statistical	tests	were	performed	using	statistical	software	
(Stata	SE,	version	13.0	for	Windows;	Stata	Corp;	College	Station,	TX)	and	a	significance	level	of	0.05.	
	
Results:	
Participants	were	47.6%	male	and	52.4%	female,	49.2%	(n=435)	had	no	OSA,	43.2%	(n=382)	had	
mild	to	moderate	OSA,	and	7.6%	(n=67)	had	severe	OSA.	Approximately	21%	of	participants	with	mild	to	
moderate	OSA	and	39%	of	those	with	severe	OSA	reported	excessive	daytime	sleepiness	(ESS	>10)	
(Table	1).	Participants	with	severe	OSA	were	significantly	older	(mean	age	=	63.7	years,	p	<.0001),	had	
higher	BMI	(mean	=	34.3	kg/m2,	p	<.0001)	and	had	lower	SF-36	PCS	scores	(45.1,	p=	.006)	than	
participants	with	no	OSA	or	those	with	mild	to	moderate	OSA.	There	was	also	a	trend	towards	lower	
scores	on	the	MCS	of	the	SF-36,	the	SAQLI,	and	the	FOSQ	(Table	2).	
When	analyzed	according	to	gender,	no	significant	differences	were	found	in	males	for	QoL	by	
OSA	severity	categories	(Table	3).	Males	with	severe	OSA	had	significantly	higher	BMI	(mean	31.9,	
p<.0001)	than	males	with	no	OSA	or	males	with	mild	to	moderate	OSA.	However,	as	shown	in	Table	4,	
females	with	severe	OSA	had	significantly	lower	mean	scores	for	the	SAQLI	(5.4,	p=	.006),	FOSQ	(10.9,	p=	
.02),	and	SF-36	PCS	(37.7,	p<.0001)	compared	to	females	with	no	OSA	and	those	with	mild	to	moderate	
OSA.	Females	with	severe	OSA	also	had	significantly	higher	BMI	(mean	41.8,	p<.0001)	than	females	with	
no	OSA	or	females	with	mild	to	moderate	OSA.		
As	shown	in	Table	5,	comparisons	between	the	QoL	measures	showed	small	correlations	
between	the	FOSQ	and	the	SF-36	MCS	(r=.31,	p	<	.001)	and	the	SF-36	PCS	(r=.37,	p	<.001),	and	medium	
correlations	between	the	SAQLI	and	the	SF-36	MCS	(r=0.52,	p	<.001)	and	the	SF-36	PCS	(r=.42,	p	<	.001).	
The	correlation	between	the	SAQLI	and	FOSQ	was	0.66,	p	<.001,	and	the	correlation	between	SF-36	MCS	
and	SF-36	PCS	was	-.024,	however	this	was	not	significant	(p	=	.142).	In	addition,	ESS	scores	were	
inversely	correlated	with	the	SAQLI	(r	=	-.36),	FOSQ	(r	=	-.43),	MCS	(r	=	-.17),	and	PCS	(r	=	-.16)	(data	not	
shown).	
Because	categorical	analyses	showed	no	difference	for	males	in	QoL	scores,	we,	therefore,	ran	
linear	regression	models	separately	for	females	and	males	(Table	6).	In	these	analyses,	AHI	severity	was	
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significant	only	for	the	SF-36	PCS	in	females	with	severe	OSA.	(coeff.	=	-8.3,	p=.004).	In	contrast,	the	ESS	
was	significant	in	models	for	all	of	the	instruments	in	both	males	and	females.	The	only	other	factor	
entering	into	some	models	was	asthma,	which	was	significant	in	models	of	the	SAQLI	and	the	PCS	in	
females.		
Discussion:	
In	these	analyses	using	a	general	(SF-36)	and	two	sleep	specific	QoL	assessment	tools	(FOSQ	and	
SAQLI),	we	found	that	QoL	was	reduced	in	those	with	severe	OSA;	substantial	differences	were	not	
apparent	among	participants	with	mild	to	moderate	OSA	and	those	with	no	OSA.	However,	there	were	
significant	gender	disparities.	Females	with	severe	OSA	demonstrated	a	substantial	reduction	in	QoL	
with	all	instruments,	but	there	was	a	lack	of	differences	among	males	by	OSA	severity.	The	reductions	in	
QoL	were	explained	primarily	by	the	presence	of	sleepiness.	Furthermore,	correlations	among	QoL	
questionnaires	were	modest	at	best,	indicating	that	they	assess	different	QoL	domains.		
	 When	males	and	females	were	analyzed	together	in	our	study,	only	the	PCS	of	the	SF-36	showed	
a	significant	reduction	in	QoL	in	participants	with	OSA,	but	this	was	limited	solely	to	participants	with	
severe	OSA.	Additional	studies	also	have	found	lower	QoL	only	in	those	with	severe	OSA.(19,	20)	
Moreover,	other	studies	have	failed	to	find	any	differences	in	QoL	among	participants	with	a	broad	
spectrum	of	OSA	severity.(21-23)	In	one	of	these	studies,	Lee	and	colleagues(22)	found	that	the	AHI	was	
not	associated	with	differences	in	the	PCS	or	MCS	of	the	SF-36	in	a	large	group	of	patients	seen	in	a	
sleep	clinic.	In	their	study,	other	factors,	such	as	age,	gender,	minimum	oxygen	saturation,	sleepiness,	
and	depression	were	associated	with	the	PCS	or	MCS	scores.	Our	study	also	found	a	strong	trend	
between	sleepiness	and	QoL	scores	for	females	and	males.	Similarly,	in	a	smaller	study,	Le	et	al(22)	did	
not	find	differences	in	the	SAQLI	among	OSA	patients	of	different	severities.	Our	data	also	are	consistent	
with	a	previous	analysis	from	the	first	examination	of	SHHS	in	which	severe	OSA	was	associated	with	
worse	QoL	on	most	subscales	of	the	SF-36,	but	only	the	vitality	subscale	was	reflective	of	poorer	QoL	in	
participants	with	OSA	of	less	severity.	In	contrast,	even	mild	OSA	was	associated	with	reduced	QoL	in	
comparison	to	no	OSA	among	the	middle-aged	males	and	females	of	the	Wisconsin	Sleep	Cohort.(24)	
However,	our	cohort	was	older	than	participants	in	the	Wisconsin	Sleep	Cohort	and	only	a	small	sample	
from	the	SHHS	was	analyzed	in	the	present	study.	Thus,	age	and	other	demographic	differences	among	
the	cohorts	may	provide	explanations	for	these	discrepancies.	Nevertheless,	despite	the	absence	of	
large	cross-sectional	differences	in	QoL	as	a	function	of	OSA	severity,	in	most	studies,	the	SF-36,	SAQLI,	
and	FOSQ	have	been	shown	to	be	sensitive	to	changes	in	QoL	after	OSA	treatment.	
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	 When	analysis	of	our	data	was	performed	separately	according	to	gender,	we	observed	that	the	
reduction	in	QoL	with	severe	OSA	was	limited	to	females	irrespective	of	the	QoL	instrument.	Other	
studies(22)	also	have	noted	that	QoL	in	participants	with	OSA	is	worse	in	women.	However,	in	a	study	of	
a	large	cohort	of	males,	Appleton	et	al.,(25)	found	that	increasing	AHI	was	associated	with	lower	QoL	on	
the	SF-36,	but	only	in	those	less	than	69	years	of	age.	The	median	age	of	the	SHHS	cohort	is	60	years	
with	substantial	numbers	of	participants	older	than	70	years.		Thus,	our	results	and	those	of	Appleton	et	
al.	may	not	be	discrepant	necessarily.	
	 Excessive	daytime	sleepiness	is	one	of	the	most	common	symptoms	in	OSA,	and	sleepiness	can	
have	a	profound	negative	impact	on	QoL.	Thus,	not	surprisingly,	our	multivariate	analyses	demonstrated	
that	the	negative	impact	of	severe	OSA	was	explained	primarily	by	the	presence	of	sleepiness.	Our	
finding	is	consistent	with	the	findings	of	some,	(19,	22,	23,	26)	but	not	all	previous	studies.(27)	The	
explanation	for	these	inconsistent	findings	is	not	readily	apparent,	but	possibilities	include	whether	
study	populations	were	recruited	from	the	general	population	or	clinic,	as	well	as	whether	the	cohorts	
had	other	co-morbidities	that	would	impact	QoL.	A	differential	perception	of	sleepiness	between	males	
and	females	offers	a	possible	explanation	of	the	greater	impact	of	OSA	on	QoL	in	the	latter.	However,	
this	assertion	seems	unlikely	inasmuch	as	previous	studies	indicate	females	with	OSA	are	more	likely	to	
report	fatigue	rather	than	sleepiness.(28-30)	
	 We	observed	that	correlations	among	the	SF-36,	SAQLI,	and	FOSQ	were	relatively	weak	to	
moderate.	Our	results	are	consistent	with	the	few	studies	that	have	done	similar	comparisons.	In	a	
Spanish	multicenter	study,(21)	correlations	of	the	FOSQ	and	several	scales	of	the	SF-36	with	the	4	
domains	of	the	SAQLI	were	poor	to	moderate.	They	ranged	from	r=.179	between	the	FOSQ	and	SAQLI	
Emotional	Functioning	domain	to	r=.579	for	the	SF-36	Vitality	and	SAQLI	Daily	Functioning	domain.	In	a	
Polish	study,(31)	the	correlation	between	the	SF-36	and	the	FOSQ	was	r=.46	and	between	the	SF-36	and	
the	SAQLI	was	r=.47.	Other	studies	have	compared	the	SF-36	to	other	general	QoL	instruments	in	
patients	with	OSA,	with	some,	but	not	all,	demonstrating	reasonable	correspondence.(32,	33)	
Considering	our	results	with	other	studies,	various	instruments	may	sample	different	aspects	of	QoL.	
Care	should	be	exercised	when	selecting	a	tool	to	assess	health	outcomes	in	OSA.	
	 There	are	several	important	limitations	to	our	findings.	First,	the	SHHS	cohort	was	recruited	
from	participants	enrolled	in	other	longitudinal	studies,	many	of	whom	were	long-time	participants.	
These	individuals	may	represent	a	group	of	survivors	who	would	generally	have	better	QoL	regardless	of	
OSA-severity	status.	Second,	as	a	group,	the	SHHS	cohort	is	older	(mean	age	=	61.6	years)	and	may	not	
be	representative	of	the	US	adult	population.	Third,	SHHS	is	a	general	population	cohort,	and	thus,	
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unlike	a	clinical	cohort,	some	did	not	have	symptoms	of	OSA.	Finally,	severity	of	OSA	may	not	be	best	
reflected	by	the	AHI.	Other	markers	of	severity	such	as	amount	of	oxygen	desaturation	or	degree	of	
sleep	fragmentation	may	be	better	surrogates	to	show	differences	in	QoL.	Nevertheless,	despite	these	
limitations,	our	analyses	have	some	unique	qualities	such	as	a	well-characterized,	racially	and	ethnically	
diverse	cohort,	use	of	home-based	polysomnography	to	assess	the	severity	of	OSA,	and	data	related	to	
QoL	derived	from	3	different	instruments.	
	 In	conclusion,	in	a	middle-aged	to	elderly	cohort,	QoL	is	poorer	only	in	females	with	severe	OSA.	
To	a	large	extent,	these	findings	can	be	explained	by	the	presence	of	daytime	sleepiness.	Correlations	
among	3	commonly	used	QoL	instruments	used	in	persons	with	OSA	were	weak	to	moderate,	suggesting	
that	each	samples	different	aspects	of	QoL.	Therefore,	care	should	be	exercised	in	selecting	a	QoL	tool	
for	documenting	health	care	outcomes	for	research	or	clinical	care.	
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Table	1.	Descriptive	characteristics.*	
	 Total	 No	OSA	 Mild-Moderate	OSA	 Severe	OSA	 p-value	
	 N	(%)	 N	(%)	 N	(%)	 N	(%)	 	
Gender	 	 	 	 	 	
Male	 421	(47.6)	 159	(36.6)	 211	(55.2)	 51	(76.1)	 	
Female	 463	(52.4)	 276	(63.4)	 171	(44.8)	 16	(23.9)	 <.0001	
Race	 	 	 	 	 	
White	 753	(85.2)	 368	(84.6)	 326	(85.3)	 59	(88.0)	 	
Black	 53	(6)	 31	(7.1)	 19	(5.0)	 3	(4.5)	 	
Hispanic	 52	(5.8))	 19	(4.4)	 28	(7.3)	 5	(7.5)	 	
Other	 26	(3)	 17	(3.9)	 9	(2.4)	 0	 .18†	
ESS	 	 	 	 	 	
≤	10	 711	(80.4)	 367	(84.4)	 303	(79.3)	 41	(61.2)	 	
>	10	 173	(19.6)	 68	(15.6)	 79	(20.7)	 26	(38.8)	 <.0001	
COPD	 	 	 	 	 	
No	 868	(98.7)	 425	(98.1)	 376	(99.2)	 67	(100)	 	
Yes	 11	(1.3)	 8	(1.8)	 3	(.8)	 0	 .37†	
Chronic	bronchitis	 	 	 	 	 	
No	 841	(95.8)	 418	(96.5)	 358	(94.7)	 65	(97.0)	 	
Yes	 37	(4.2)	 15	(3.5)		 20	(5.3)	 2	(3.0)	 .38	
Asthma	 	 	 	 	 	
No	 758	(86.2)	 373	(86.3)	 330	(86.8)	 55	(82.1)	 	
Yes	 121	(13.4)	 59	(13.7)	 50	(13.2)	 12	(17.9)	 .58	
*p-value	for	Chi-square	test	for	gender,	ESS,	chronic	bronchitis,	and	asthma	by	OSA	category.	†Fisher’s	exact	test	for	race	and	COPD.	
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Table	2.	Descriptive	characteristics	by	OSA	categories.*	
	 Total	 No	OSA	 Mild-Moderate	OSA	 Severe	OSA	 p-value	
	 Mean	(SD)	 Mean	(SD)	 Mean	(SD)	 Mean	(SD)	 	
Age	(years)	 61.6	(10)	 59.5	(9.6)	 63.2	(9.5)	 63.7	(10.3)	 <.0001	
BMI	(kg/m2)	 28.6	(5.7)	 26.7	(4.4)	 29.9	(5.6)	 34.3	(7.8)	 <.0001	
Total	sleep	time†	 384.5	(64.7)	 386.9	(63.0)	 383.4	(67.7)	 374.1	(57.4)	 .29	
SAQLI	 6.0	(.82)	 6.0	(.78)	 6.0	(.83)	 5.8	(.8)	 .11	
FOSQ	 11.5	(.82)	 11.5	(.78)	 11.5	(.84)	 11.4	(.91)	 .37	
SF-36	MCS	 54.0	(8.2)	 53.8	(8.0)	 54.4	(8.4)	 55.3	(7.4)	 .32	
SF-36	PCS	 47.1	(10.8)	 48.5	(10.5)	 46.5	(11.0)	 45.1	(10.3)	 .006	
*	p-value	for	ANOVA	test	for	each	descriptive	variables	by	OSA	category.	†Time	in	minutes.		
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Table	3.	Descriptive	characteristics	for	QoL	questionnaires	by	OSA	categories	for	males.*	
	 	
	 No	OSA	 Mild-Moderate	OSA	 Severe	OSA	 p-value	
	 Mean	(SD)	 Mean	(SD)	 Mean	(SD)	 	
BMI	(kg/m2)	 27.0	(3.5)	 29.5	(4.2)	 31.9	(5.0)	 <.0001	
Total	sleep	time†	 377.0	(59.6)	 370.4	(68.3)	 371.4	(56.8)	 .60	
SAQLI	 6.0	(.73)	 6.0	(.8)	 5.9	(.7)	 .69	
FOSQ	 11.6	(.7)	 11.5	(.86)	 11.6	(.82)	 .72	
SF-36	MCS	 53.8	(8.1)	 54.7	(7.9)	 55.7	(7.0)	 .25	
SF-36	PCS	 49.3	(9.4)	 48.0	(10.3)	 47.4	(8.9)	 .33	
*p-value	for	ANOVA	test.	
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Table	4.	Descriptive	characteristics	for	QoL	questionnaires	by	OSA	categories	for	females.*	
	 	
	 No	OSA	 Mild-Moderate	OSA	 Severe	OSA	 p-value	
	 Mean	(SD)	 Mean	(SD)	 Mean	(SD)	 	
BMI	(kg/m2)	 26.5	(4.7)	 30.6	(6.9)	 41.8	(9.9)	 <.0001	
Total	sleep	time†	 392	(64.3)	 399.5	(63.6)	 382.6	(60.3)	 .41	
SAQLI	 6.0	(.8)	 5.9	(.86)	 5.4	(.97)	 .006	
FOSQ	 11.5	(.82)	 11.4	(.8)	 10.9	(1.03)	 .02	
SF-36	MCS	 53.8	(7.9)	 53.9	(8.9)	 53.8	(8.3)	 .99	
SF-36	PCS	 48.0	(11.0)	 44.6	(11.6)	 37.7	(11.1)	 <.0001	
*p-value	for	ANOVA	test.	
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Table	5.	Correlation	for	SAQLI,	FOSQ,	SF-36	MCS,	and	SF-36	PCS.*	
	 SAQLI	 FOSQ	 SF-36	MCS	 SF-36	PCS	
SAQLI	 1	 	 	 	
FOSQ	 0.66	(<0.001)	 1	 	 	
SF-36	MCS	 0.52	(<0.001)	 0.31	(<0.001)	 1	 	
SF-36	PCS	 0.42	(<0.001)	 0.37	(<0.001)	 -0.024	(0.142)	 1	
*	r	(p-value)	for	Pearson	correlation	
	
	
	
	
	
Table	6.	Linear	Regression	models	predicting	QoL	scores	by	OSA	category	for	females	and	males.	
	 Female	 	 Male	
	 Coefficient	 p-value	 95%	CI	 	 Coefficient	 p-value	 95%	CI*	
	 	 	 	 	 	 	 	
SAQLI	 	 	 	 	 	 	 	
Mild-Moderate	OSA	 .02	 .72	 -.12	–	.17	 	 .03	 .69	 -.12	–	.18	
Severe	OSA	 -.35	 .07	 -.73	–	.03		 	 -.002	 .98	 -.23	–	.23	
Asthma	 -.25	 .01	 -.44	–	-.05	 	 -.19	 .08	 -.41	–	.03	
ESS	 -.08	 <.0001	 	 -.09	–	-.06	 	 -.04	 <.0001	 -.06	–	-.03	
Constant	 6.6	 <.0001	 6.4	–	6.7	 	 6.4	 <.0001	 6.2	–	6.6	
	 	 	 	 	 	 	 	
FOSQ	 	 	 	 	 	 	 	
Mild-Moderate	OSA	 .03	 .66	 -.11	-	.17	 	 -.03	 .63	 -.19	–	.11	
Severe	OSA	 -.17	 .35	 -.54	–	.19	 	 .07	 .58	 -.17	–	.31	
Asthma	 -.11	 .25	 -.29	–	.07	 	 .03	 .74	 -.18	–	.26	
ESS	 -.10	 <.0001	 -.12	–	-.08	 	 -.06	 <.0001	 -.08	–	-.04	
Constant	 12.1	 <.0001	 12.0	–	12.3	 	 12.1	 <.0001	 11.9	–	12.2	
	 	 	 	 	 	 	 	
SF-36	MCS	 	 	 	 	 	 	 	
Mild-Moderate	OSA	 .84	 .30	 -.75	–	2.4	 	 1.0	 .20	 -.57	–	2.6	
Severe	OSA	 1.7	 .40	 -2.4	–	6.0	 	 2.2	 .07	 -.22	–	4.7	
Asthma	 -1.7	 .11	 -3.8	–	.41	 	 .20	 .86	 -2.1	–	2.5	
ESS	 -.44	 <.0001	 -.63	–	-.25	 	 -.21	 .02	 -.39	–	-.02	
Constant	 56.8	 <.0001	 55.2	–	58.3	 	 55.3	 <.0001	 53.5	–	57.1	
	 	 	 	 	 	 	 	
SF-36	PCS	 	 	 	 	 	 	 	
Mild-Moderate	OSA	 -2.5	 .02	 -4.7	–	-.39	 	 -1.3	 .21	 -3.3	–	.74	
Severe	OSA	 -8.3	 .004	 -13.9	–	-2.6	 	 -1.5	 .34	 -4.6	–	1.6	
Asthma	 -3.9	 .007	 -6.7	–	-1.0	 	 -2.6	 .08	 -5.5	–	.28	
ESS	 -.44	 <.001	 -.69	–	-.18	 	 -.23	 .04	 -.46	–	-.01	
Constant	 51.3	 <.0001	 49.2	–	53.3	 	 51.3	 <.0001	 49.1	–	53.6	
*CI	=	Confidence	interval	
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